CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/22/2023
Back to search
Official data from USPTO
ZOSANO PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ZOSANO PHARMA
ST13
US500000077256850Class
5, 10
Filing
77256850
Registration
3705884
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
67
Latest update
05/22/2023
Trademark type
Word
Nice classes
5, 10
Filing date
08/16/2007
Registration date
11/03/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2019
Last transaction
05/22/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2008-06-00
First use in commerce
2008-06-00
Drawing code
4
Owner type
03
Owner location
Doylestown, PA
Examiner
CASTRO, GIANCARLO
Law office
M10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
E. C. (pessoa física)
Z. C. (pessoa física)
ZP OPCO, INC.
ZOSANO PHARMA, INC.
M. C. (pessoa física)
Representatives
Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard & Geralds
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
transdermal drug patches sold with medication for use in the treatment of paininfectious diseasescardiovascularneurological*treatment* metabolic and endocrinology disorders; transdermal drug patches sold with medication in the nature of vaccines ; intradermal drug delivery devices sold with medication in the nature of vaccines; intradermal drug delivery devices sold with medication in the nature of patches to deliver therapeutic drugs and biopharmaceuticals into the body to treat paininfectious diseasescardiovascularneurologicalmetabolic and endocrinology disorders
Class 10
Intradermal drug delivery devices sold without medication
Publications
History of USPTO decisions and trademark events.
67 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/22/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/22/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/22/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/22/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/12/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/27/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/27/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/27/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/26/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
08/19/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/03/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/11/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/16/2015
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/30/2015
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/30/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/30/2015
ES8R
TEAS SECTION 8 RECEIVED
10/15/2015
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
10/04/2012
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
10/04/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
11/03/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
09/27/2009
ALIE
ASSIGNED TO LIE
09/25/2009
ALIE
ASSIGNED TO LIE
09/22/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/14/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/25/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/25/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/24/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/13/2009
GNRT
NON-FINAL ACTION E-MAILED
08/13/2009
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/13/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/30/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/30/2009
IUAF
USE AMENDMENT FILED
07/08/2009
EISU
TEAS STATEMENT OF USE RECEIVED
07/08/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
01/13/2009
PUBO
PUBLISHED FOR OPPOSITION
10/21/2008
NPUB
NOTICE OF PUBLICATION
10/01/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/17/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/10/2008
GNRT
NON-FINAL ACTION E-MAILED
09/10/2008
CNRT
NON-FINAL ACTION WRITTEN
09/10/2008
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/10/2008
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/25/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/13/2008
ALIE
ASSIGNED TO LIE
07/30/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/30/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/30/2008
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/30/2008
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/25/2008
GNFR
FINAL REFUSAL E-MAILED
06/25/2008
CNFR
FINAL REFUSAL WRITTEN
06/25/2008
DOCK
ASSIGNED TO EXAMINER
05/29/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2008
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/06/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/30/2007
GNRT
NON-FINAL ACTION E-MAILED
11/30/2007
CNRT
NON-FINAL ACTION WRITTEN
11/30/2007
DOCK
ASSIGNED TO EXAMINER
11/26/2007
NWAP
NEW APPLICATION ENTERED
08/20/2007
Continuous trademark protection
Get notified about every new filing that threatens ZOSANO PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.